Trials / Conditions / Primary Pulmonary Hypertension

Primary Pulmonary Hypertension

8 registered clinical trials studyying Primary Pulmonary Hypertension.

Status	Trial	Sponsor	Phase
Terminated	Efficacy and Safety of Riociguat in Incipient Pulmonary Vascular Disease as an Indicator for Early PAH NCT05339087	Heidelberg University	Phase 2
Completed	Carnitine Consumption and Augmentation in Pulmonary Arterial Hypertension NCT04908397	Vanderbilt University Medical Center	Phase 1
Active Not Recruiting	Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of NCT03992755	Liquidia Technologies, Inc.	Phase 3
Completed	Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension NCT03528902	Vanderbilt University Medical Center	Phase 2
Completed	Investigation of the Safety and Pharmacology of Dry Powder Inhalation of Treprostinil NCT03399604	Liquidia Technologies, Inc.	Phase 3
Completed	The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary O NCT02859194	Yonsei University	N/A
Withdrawn	Efficacy Study of Cardizem in Pulmonary Arterial Hypertension NCT01645826	University of South Florida	N/A
Terminated	Reversible Secondary Myelofibrosis or Clonal Myeloproliferative Disorder NCT00722254	University of Utah	—